Synapse Open Synapse
Biology

Novartis reveals cancer cases possibly linked to gene therapy Zolgensma

BioPharma Dive · · 3 min read

The FDA is now investigating the risk of malignancy associated with Zolgensma and is “evaluating whether regulatory action is appropriate.”

Latest from BioPharma Dive